A phase 1a/b study of BR101801, a PI3K gamma delta and DNA PK triple inhibitor, in adult patients with advanced hematologic malignancies
JOURNAL OF CLINICAL ONCOLOGY(2023)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
JOURNAL OF CLINICAL ONCOLOGY(2023)